Kaleido Biosciences is a healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health.
Business Model:
Revenue: $1.1M
Employees: 51-200
Address: 65 Hayden Avenue
City: Lexington
State: MA
Zip: 02421
Country: US
Kaleido Biosciences is a healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health.
Contact Phone:
+16176749000
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/27/2019
IPO Valuation:
$444M
Ticker Symbol:
KLDO
IPO Price:
$15/share
Amount Raised:
$75M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2015 | Series A | - | 8/2015 | Series A | $4.5M | 2/2021 | Post-IPO Equity | $60.4M | 6/2017 | Series B | $65M |
Flagship Pioneering |
6/2018 | Series C | 5 | $101M |
Invus Abu Dhabi Investment Authority Rock Springs Capital Fidelity Management and Research Company Flagship Pioneering Invus Abu Dhabi Investment Authority Rock Springs Capital Fidelity Management and Research Company Flagship Pioneering |
9/2017 | Series B | 2 | $65M |
Michael Bonney Flagship Pioneering Flagship Pioneering Michael Bonney Michael Bonney Flagship Pioneering Flagship Pioneering Michael Bonney |
8/2015 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|